Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer

NCT02540356 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Ovarian Cancer With Recurrent Symptomatic Malignant Ascites

Interventions

BIOLOGICAL: BAX69 Single-Route Arm
BIOLOGICAL: BAX69 Double-Route Arm

Sponsor

Baxalta now part of Shire